Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 122

    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Roche gets USFDA nod for combo lymphoma treatment Polivy

    Medical Dialogues Bureau11 Jun 2019 9:30 AM IST
    Polivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
    Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

    Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20

    Medical Dialogues Bureau11 Jun 2019 9:15 AM IST
    The growth would primarily better revenues from its drug Copaxone as projected by Natco Pharma's marketing partner Mylan and also improved performance...
    Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

    Opioid drugmaker Insys Therapeutics files for bankruptcy after kickback probe

    Medical Dialogues Bureau11 Jun 2019 9:00 AM IST
    The filing in U.S. Bankruptcy Court in the District of Delaware made Insys Therapeutics the first drug manufacturer to turn to bankruptcy due to legal...
    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Dr Reddys yields positive results from phase 2b study of new psoriasis drug

    Farhat Nasim10 Jun 2019 2:02 PM IST
    The detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
    USFDA okays marketing of first medical device IB-Stim to treat IBS pain

    USFDA okays marketing of first medical device IB-Stim to treat IBS pain

    Medical Dialogues Bureau10 Jun 2019 9:45 AM IST
    The IB-Stim is a prescription-only medical device comprised of a small single-use electrical nerve stimulator that is placed behind the patient’s ear....
    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Farhat Nasim10 Jun 2019 9:30 AM IST
    Roche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
    Merck, Rigaku partner to develop novel molecular structure analysis technology

    Merck, Rigaku partner to develop novel molecular structure analysis technology

    Farhat Nasim10 Jun 2019 9:15 AM IST
    The partnership creates an outstanding strategic opportunity for both companies, Merck and Rigaku to establish leading products for chemical...
    Global forum to examine use of safer nicotine products

    Global forum to examine use of safer nicotine products

    Farhat Nasim10 Jun 2019 9:00 AM IST
    The forum will examine the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses.New Delhi: Amid a...
    GSK Nucala wins USFDA approval for two new self-administration options

    GSK Nucala wins USFDA approval for two new self-administration options

    Farhat Nasim9 Jun 2019 10:00 AM IST
    Nucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
    Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

    Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

    Medical Dialogues Bureau9 Jun 2019 9:40 AM IST
    Healthians is looking for more acquisitions to fuel its aggressive growth plans and plans to invest over USD 5 million to expand its services to...
    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Medical Dialogues Bureau9 Jun 2019 9:30 AM IST
    In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Novartis gets new pharma chief Marie-France Tschudin; bids farewell to Paul Hudson

    Farhat Nasim9 Jun 2019 9:25 AM IST
    Marie-France Tschudin succeeds Paul Hudson who will be leaving Novartis to take the CEO position of a multinational pharmaceuticals company.Basel:...
    PrevNext

    Popular Stories

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

    Embracing the Vegetarian Lifestyle: 5 Habits You Need to Have Right Away

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok